替雷利珠单抗诱导的中毒性表皮坏死松解症样皮肤不良反应：免疫检查点抑制剂治疗的罕见并发症 - Suppr

Suppr

超能文献

Tislelizumab-Induced Toxic Epidermal Necrolysis-Like Cutaneous Adverse Reaction: Rare Complication of Immune Checkpoint Inhibitor Therapy.

作者信息

Yang Xiaoqin, Xu Shunming

机构信息

Department of Dermatology, Shanghai Pudong New Area People's Hospital, Shanghai, China.

出版信息

Am J Ther. 2024;31(4):e470-e474. doi: 10.1097/MJT.0000000000001682.

DOI:10.1097/MJT.0000000000001682

PMID:38976533

Abstract

摘要

相似文献

Tislelizumab-Induced Toxic Epidermal Necrolysis-Like Cutaneous Adverse Reaction: Rare Complication of Immune Checkpoint Inhibitor Therapy.替雷利珠单抗诱导的中毒性表皮坏死松解症样皮肤不良反应：免疫检查点抑制剂治疗的罕见并发症

Am J Ther. 2024;31(4):e470-e474. doi: 10.1097/MJT.0000000000001682.

Immunohistochemical Expression of PD-L1 Is Increased in Lesional Epidermal Keratinocytes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.在史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症中，病变表皮角质形成细胞中PD-L1的免疫组化表达增加。

Am J Dermatopathol. 2021 Apr 1;43(4):318-320. doi: 10.1097/DAD.0000000000001816.

Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma.帕博利珠单抗诱发的转移性食管腺癌患者中毒性表皮坏死松解症

R I Med J (2013). 2022 Apr 1;105(3):34-36.

Toxic epidermal necrolysis occurring with immune checkpoint inhibitors.免疫检查点抑制剂相关的中毒性表皮坏死松解症。

Dermatol Online J. 2020 Aug 15;26(8):13030/qt8fc428f6.

Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症与免疫检查点抑制剂相关：系统评价。

Front Immunol. 2024 Jul 12;15:1414136. doi: 10.3389/fimmu.2024.1414136. eCollection 2024.

Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study.肿瘤坏死因子抑制剂增强与免疫检查点抑制剂相关的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的皮质类固醇治疗：一项前瞻性研究。

Front Immunol. 2024 Aug 7;15:1421684. doi: 10.3389/fimmu.2024.1421684. eCollection 2024.

Pembrolizumab associated Stevens-Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma.帕博利珠单抗相关史蒂文斯-约翰逊综合征伴原发性肝细胞癌患者的角化不良。

Australas J Dermatol. 2022 Feb;63(1):e71-e74. doi: 10.1111/ajd.13704. Epub 2021 Aug 31.

Toxic epidermal necrolysis post apalutamide with preceding tislelizumab administration in a patient with two cancers.一名患有两种癌症的患者在使用阿帕鲁胺后出现中毒性表皮坏死松解症，之前曾使用过替雷利珠单抗。

J Dtsch Dermatol Ges. 2023 Oct;21(10):1221-1223. doi: 10.1111/ddg.15150. Epub 2023 Aug 31.

[Toxic epidermal necrolysis due to anti-PD1 treatment with fatal outcome].[抗程序性死亡蛋白1治疗导致中毒性表皮坏死松解症并致死]

Ann Dermatol Venereol. 2017 Jan;144(1):65-66. doi: 10.1016/j.annder.2016.11.012. Epub 2016 Dec 20.

Ocular manifestations of anti-neoplastic immune checkpoint inhibitor-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in cancer patients.癌症患者中抗肿瘤免疫检查点抑制剂相关的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的眼部表现

Ocul Surf. 2021 Oct;22:47-50. doi: 10.1016/j.jtos.2021.06.010. Epub 2021 Jun 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Tislelizumab-Induced Toxic Epidermal Necrolysis-Like Cutaneous Adverse Reaction: Rare Complication of Immune Checkpoint Inhibitor Therapy.

作者信息

Yang Xiaoqin, Xu Shunming

机构信息

Department of Dermatology, Shanghai Pudong New Area People's Hospital, Shanghai, China.

出版信息

Am J Ther. 2024;31(4):e470-e474. doi: 10.1097/MJT.0000000000001682.

DOI:10.1097/MJT.0000000000001682

PMID:38976533

Abstract

摘要